IL9 and neoplasm: To investigate the mechanism underlying the antitumor effect of IL9 on the macrophage-enriched tumor model, we collected tumor masses after euthanizing the tumor-bearing mice (n = 4) on day 15 after tumor implantation (Fig. 3C).